These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7282676)

  • 21. Savings achieved through cephalosporin surveillance.
    Katz E; Schlamowitz S
    Am J Hosp Pharm; 1978 Dec; 35(12):1521-3. PubMed ID: 717407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Formularies: the role of pharmacy-and-therapeutics (P&T) committees.
    Summers KH; Szeinbach SL
    Clin Ther; 1993; 15(2):433-41; discussion 432. PubMed ID: 8519049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strategic planning for the management of biotechnologic products: development of a biotech committee.
    Akinwande K; Tse T; Darab M; Madura A; Cerceo R; Al-Hani A
    Hosp Formul; 1993 Sep; 28(9):773-4, 777-80. PubMed ID: 10128393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Achieving an effective committee through reorganization: the Ohio State University Hospital's experience.
    Lewis RP; Moore TD
    Hosp Formul; 1991 Feb; 26(2):120-30. PubMed ID: 10109143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. P & T Committee interview: communication and education contribute to an effective formulary system.
    Hinthorn D; Godwin H
    Hosp Formul; 1989 May; 24(5):281-4, 286-7. PubMed ID: 10292977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experience with a two-tiered therapeutic interchange policy.
    Rich DS
    Am J Hosp Pharm; 1989 Sep; 46(9):1792-8. PubMed ID: 2572167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formulary decision making in a specialty hospital: effective management of potent and costly drug therapies.
    Keating MJ; Dana WJ
    Hosp Formul; 1990 Jun; 25(6):639-44. PubMed ID: 10113244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. P & T Committee interview: Establishing and maintaining a dynamic formulary.
    Rostand S; Lazarus H
    Hosp Formul; 1988 Jan; 23(1):48-53. PubMed ID: 10285373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Communicating P & T guidelines: how one committee meets the challenge.
    Dreyfus R; Bender F
    Hosp Formul; 1987 Jul; 22(7):651-4, 657. PubMed ID: 10282681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hospital formularies: organizational aspects and supplementary components.
    Rucker TD; Visconti JA
    Am J Hosp Pharm; 1976 Sep; 33(9):912-7. PubMed ID: 984056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. P&T Committee antibiotic cost considerations.
    Rinehart JR
    Hosp Formul; 1986 Aug; 21(8):857-9, 862-4. PubMed ID: 10277580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishing an enteral product formulary.
    Ford DB; Bergerson SL; Henderson P; Murphy J; Peter J
    J Am Diet Assoc; 1989 May; 89(5):681-3. PubMed ID: 2498416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost savings through formulary implementation and group purchasing in four therapeutic categories.
    Sylvester KL; Wudds TW
    Hosp Formul; 1986 Mar; 21(3):357-60, 369-70. PubMed ID: 10275579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Key inventory to formulary to cut drug costs.
    Schmieding JL; Sita MJ
    Hospitals; 1980 Sep; 54(17):78-81. PubMed ID: 7399457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of removing oral neuroleptic liquids from the formulary of a large psychiatric hospital.
    Jewett C; Sramek J; Itow G; Alcorn V
    Hosp Formul; 1988 Mar; 23(3):288-91, 295-6. PubMed ID: 10314656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What process does your P&T Committee use to obtain staff physicians' input regarding formulary decisions?
    Tompkins GC
    Hosp Formul; 1992 Feb; 27(2):197. PubMed ID: 10116717
    [No Abstract]   [Full Text] [Related]  

  • 37. Formulary management at a tertiary-care facility: P&T committee interview.
    Lucas RV; Abramowitz PW
    Hosp Formul; 1988 Feb; 23(2):162-8, 172-3. PubMed ID: 10286021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formulary decision making: identifying factors that influence P&T committee drug evaluations.
    Segal R; Pathak DS
    Hosp Formul; 1988 Feb; 23(2):174-8. PubMed ID: 10286022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multidisciplinary process to determine, communicate, and manage an antibiotic formulary.
    Cook AA; Sanchez ML
    Hosp Pharm; 1992 Oct; 27(10):867-9, 872-4, 882. PubMed ID: 10121423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug product selection by formulary committees in Sweden.
    Lilja J
    Am J Hosp Pharm; 1979 Aug; 36(8):1042, 1044. PubMed ID: 484560
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.